On the other hand, when expressed as a transgene in mice, Erk2T188D enhances cardiac hypertrophy (11), raising the possibility that Erk1/2 proteins mutated in T207/188 are perhaps active in vivo although not active as recombinant proteins. The gene discussed is MAPK3; the disease is cardiac hypertrophy.